Johnson & Johnson (NYSE:JNJ) Stock Holdings Decreased by EFG Asset Management Americas Corp.

EFG Asset Management Americas Corp. lowered its stake in Johnson & Johnson (NYSE:JNJ) by 60.4% in the 1st quarter, Holdings Channel.com reports. The firm owned 21,664 shares of the company’s stock after selling 33,055 shares during the period. EFG Asset Management Americas Corp.’s holdings in Johnson & Johnson were worth $3,593,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Conquis Financial LLC bought a new stake in shares of Johnson & Johnson during the 4th quarter valued at about $33,000. Bernard Wealth Management Corp. bought a new stake in shares of Johnson & Johnson during the 4th quarter valued at about $36,000. Highline Wealth Partners LLC grew its position in shares of Johnson & Johnson by 51.8% during the 1st quarter. Highline Wealth Partners LLC now owns 252 shares of the company’s stock valued at $42,000 after buying an additional 86 shares during the last quarter. von Borstel & Associates Inc. bought a new stake in shares of Johnson & Johnson during the 1st quarter valued at about $49,000. Finally, Capital A Wealth Management LLC bought a new stake in shares of Johnson & Johnson during the 4th quarter valued at about $50,000. Institutional investors own 69.55% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Leerink Partners downgraded shares of Johnson & Johnson from an “outperform” rating to a “market perform” rating and lowered their price objective for the company from $169.00 to $153.00 in a research report on Tuesday, May 13th. Barclays upped their target price on shares of Johnson & Johnson from $165.00 to $176.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 17th. Sanford C. Bernstein restated a “market perform” rating on shares of Johnson & Johnson in a research report on Wednesday, April 16th. Benchmark upgraded shares of Johnson & Johnson to a “strong-buy” rating in a research report on Thursday, April 24th. Finally, Wall Street Zen cut shares of Johnson & Johnson from a “strong-buy” rating to a “buy” rating in a research report on Friday, July 18th. Nine investment analysts have rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $174.50.

Johnson & Johnson Trading Down 0.5%

Johnson & Johnson stock opened at $167.31 on Thursday. Johnson & Johnson has a 12-month low of $140.68 and a 12-month high of $169.99. The stock has a market capitalization of $402.94 billion, a PE ratio of 17.89, a price-to-earnings-growth ratio of 2.14 and a beta of 0.41. The firm has a 50 day simple moving average of $156.93 and a 200-day simple moving average of $156.30. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.01 and a quick ratio of 0.76.

Johnson & Johnson (NYSE:JNJ) last released its earnings results on Wednesday, July 16th. The company reported $2.77 EPS for the quarter, beating the consensus estimate of $2.68 by $0.09. Johnson & Johnson had a net margin of 25.00% and a return on equity of 32.49%. The business had revenue of $23.74 billion during the quarter, compared to analyst estimates of $22.85 billion. During the same period in the prior year, the business earned $2.82 earnings per share. The business’s quarterly revenue was up 5.8% on a year-over-year basis. As a group, equities research analysts expect that Johnson & Johnson will post 10.58 EPS for the current fiscal year.

Johnson & Johnson Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Investors of record on Tuesday, August 26th will be paid a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 3.11%. The ex-dividend date of this dividend is Tuesday, August 26th. Johnson & Johnson’s dividend payout ratio is presently 55.61%.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.